Studies of the XRCC1 Gln399Gln polymorphism of the Polish population showed that the risk of death from lung malignancy was higher in adenocarcinoma patients with XRCC1 Gln/Gln genotypes, although their frequency was low. This evidence concerns the gene XRCC1 and adenocarcinoma.